Today's News |
|
Pfizer Proposes Expansion of Late-Stage Coronavirus Vaccine Trial
Monday, September 14, 2020
Vancouver, BC, September 12, 2020--Pfizer and biotech firm BioNTech announced Saturday that they have submitted a proposal to the U.S. Food and Drug Administration to expand the phase-three trial of its coronavirus vaccine to include up to 44,000 participants, a significant increase. The companies, which are developing the vaccine together, said in a statement that the trial is proceeding as planned and they expect to have enrolled 30,000 participants by next week.
|
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|